Table 4.
Early postoperative outcomes in groups LSG vs. LRYGB
| Total | LSG | LRYGB | p | |
|---|---|---|---|---|
| n | 574 (100%) | 364 (63.41%) | 210 (36.59%) | – |
| Mean operative time (min ± SD) | 121.07 ± 47.86 | 105.99 ± 39.95 | 146.23 ± 49.45 | < 0.001 |
| Median operative time (min, IQR) | 115 (87.5–150) | 100 (80–120) | 140 (110–180) | |
| Mean IV fluid administration during the operation (ml ± SD) | 1416.56 ± 525.32 | 1336.05 ± 501.87 | 1552.47 ± 537.24 | < 0.001 |
| Intraoperative adverse events | 24 (4.18%) | 12 (3.3%) | 12 (5.71%) | 0.163 |
| Postoperative complications | 44 (7.67%) | 26 (7.14%) | 18 (8.57%) | 0.542 |
| Clavien-Dindo I–II | 27 (4.7%) | 18 (4.95%) | 9 (4.29%) | 0.719 |
| Clavien-Dindo III–V | 17 (2.96%) | 8 (2.2%) | 9 (4.29%) | 0.155 |
| Biochemical rhabdomyolysis | 10 (1.74%) | 3 (0.82%) | 7 (3.33%) | 0.916 |
| Gastrointestinal leakage | 6 (1.05%) | 4 (1.1%) | 2 (0.95%) | 0.868 |
| Gastrointestinal stricture | 9 (1.57%) | 7 (1.92%) | 2 (0.95%) | 0.367 |
| Postoperative hemorrhage | 7 (1.22%) | 3 (0.82%) | 4 (1.9%) | 0.256 |
| Wound infection | 2 (0.35%) | 1 (0.27%) | 1 (0.48%) | 0.759 |
| Pneumonia | 6 (1.05%) | 2 (0.55%) | 4 (1.9%) | 0.124 |
| Reoperations | 9 (1.57%) | 5 (1.37%) | 4 (1.9%) | 0.317 |